Patent for organoid MEA granted by USPTO

🎉 We’re excited to share that our patent titled “Soft & Stretchable Microelectrode Arrays (sMEAs) with 3D Pocket and Microfluidic Channel” has been officially granted by the USPTO (US 12,533,673 B2).

This innovation introduces a novel organoid #MEA platform designed to enable 3D electrophysiological recording from brain organoids. By enhancing the physiological relevance of in-vitro models, this technology supports deeper insights into brain function and advances preclinical drug screening for neurological and neurodegenerative diseases.

BMSEED’s stretchable microelectrode technology enables the creation of customizable 3D pockets that contain organoids, preserve their structure and physiological integrity, and enable neural signal monitoring across as much of the intact organoid surface as possible. This represents an important step toward improving disease modeling and accelerating therapeutic discovery.

We gratefully acknowledge the National Institute of Neurological Disorders and Stroke (NINDS) for funding the research that made this achievement possible. We also thank David Bilodeau and the team at Birch, Stewart, Kolasch & Birch, LLP (BSKB) for their valuable contributions. Lastly, we thank the City of Mesa and the economic development team around Kelley Keffer for their enthusiastic support of BMSEED.

🔗 Read the full patent here: https://patents.google.com/patent/US20240082843A1/en